2D–shear-wave elastography example: non-MAFLD CKD case (male, 54 years). 著者: Zienab M. Saad (22676502)

その他の著者:

2D–shear-wave elastography example: MAFLD + CKD case (male, 65 years). 著者: Zienab M. Saad (22676502)

その他の著者:

eGFR in the study participants. 著者: Zienab M. Saad (22676502)

その他の著者:

Demographic and Clinical Characteristics of Study Participants. 著者: Zienab M. Saad (22676502)

その他の著者:

Stratification of Liver Stiffness according to eGFR in the MAFLD group. 著者: Zienab M. Saad (22676502)

その他の著者:

Medication-inclusive multivariable logistic regression for MAFLD. 著者: Zienab M. Saad (22676502)

その他の著者:

Receiver operating characteristic (ROC) curve analysis comparing the performance of non-invasive fibrosis scores in MAFLD patients. 著者: Zienab M. Saad (22676502)

その他の著者:

Comparison of Non-invasive Liver Fibrosis Scores. 著者: Zienab M. Saad (22676502)

その他の著者:

A. Violin plots showing eGFR distribution in MAFLD (red) vs. non-MAFLD (blue) groups. 著者: Zienab M. Saad (22676502)

その他の著者:

Proposed pathophysiological crosstalk between MAFLD and CKD. 著者: Zienab M. Saad (22676502)

その他の著者:

Liver Stiffness and Fibrosis Grading by MAFLD Status. 著者: Zienab M. Saad (22676502)

その他の著者:

2D–shear-wave elastography example: MAFLD + CKD case (female, 57 years). 著者: Zienab M. Saad (22676502)

その他の著者:

Grades of liver fibrosis in MAFLD group (grey) and non-MAFLD group (black). 著者: Zienab M. Saad (22676502)

その他の著者:

Multivariable logistic regression models for MAFLD predictors. 著者: Zienab M. Saad (22676502)

その他の著者:

Liver Fibrosis Characteristics by CKD Stage in MAFLD Patients (n = 64). 著者: Zienab M. Saad (22676502)

その他の著者: